Literature DB >> 30396977

C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer.

Yuki Fujiwara1, Koichiro Haruki2, Hiroaki Shiba2, Ryoga Hamura2, Takashi Horiuchi2, Yoshihiro Shirai2, Kenei Furukawa2, Takeshi Gocho2, Katsuhiko Yanaga2.   

Abstract

AIM: Prognostic factors of recurrence and survival in various cancer types have been reported and include C-reactive protein (CRP)-based measures as evidenced by the Glasgow prognostic score (GPS), as well as peripheral blood cell-based prognostic values such as the prognostic index (PI), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR). The aim of this study was to identify significant prognostic values and compare them for suitability for use in patients after curative pancreatic resection for pancreatic cancer.
MATERIALS AND METHODS: Between 2000 and 2015, 188 patients were enrolled in this retrospective study. The relationship between clinicopathological variables including various prognostic values and disease-free (DFS) and overall (OS) survival was investigated by univariate analysis. The area under the receiver operating characteristics curve (AUC) was evaluated to compare the predictive ability of each of these scoring systems. Multivariate analysis was then performed to identify clinicopathological variables that associated DFS and OS.
RESULTS: In univariate analysis, GPS, modified GPS, CRP to albumin ratio and PI were significant risk factors for both DFS and OS. The AUC of CRP-based scores (GPS, modified GPS, and CRP to albumin ratio) were consistently larger in comparison with PI, which consists of both CRP and peripheral blood cell scores, at all time points for both DFS and OS. In multivariate analysis, GPS was the only independent risk factor of tumor recurrence and survival.
CONCLUSION: CRP-based prognostic scores have an independent value for both tumor recurrence and prognosis in patients after curative resection for pancreatic cancer, and are superior to other peripheral blood cell count-based prognostic scores. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  C-reactive protein; CRP-based prognostic values; Glasgow prognostic score; Pancreatic cancer

Mesh:

Substances:

Year:  2018        PMID: 30396977     DOI: 10.21873/anticanres.13013

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.

Authors:  Wen Fu; Kun Wang; Shan Yan; Xie Wang; Bo Tang; Jiang Chang; Ran Wang; Tao Wu
Journal:  Dose Response       Date:  2020-08-03       Impact factor: 2.658

2.  The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.

Authors:  Huan Zhang; Dianyun Ren; Xin Jin; Heshui Wu
Journal:  Cancer Cell Int       Date:  2020-09-22       Impact factor: 5.722

3.  The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer.

Authors:  Tomohiko Taniai; Koichiro Haruki; Kenei Furukawa; Shinji Onda; Jungo Yasuda; Yoshihiro Shirai; Takeshi Gocho; Mitsuru Yanagaki; Ryoga Hamura; Hiroaki Shiba; Toru Ikegami
Journal:  Int J Clin Oncol       Date:  2021-06-10       Impact factor: 3.402

4.  Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.

Authors:  Qinfen Xie; Lidong Wang; Shusen Zheng
Journal:  Dose Response       Date:  2020-06-29       Impact factor: 2.658

5.  Associations between Dietary Acid Load and Biomarkers of Inflammation and Hyperglycemia in Breast Cancer Survivors.

Authors:  Tianying Wu; Phoebe Seaver; Hector Lemus; Kathryn Hollenbach; Emily Wang; John P Pierce
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717

6.  C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers: A meta-analysis.

Authors:  Yan-Jun Fu; Ke-Zhi Li; Ji-Hong Bai; Zhi-Qing Liang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.

Authors:  Dongdong Wu; Xingmu Wang; Ge Shi; Honggang Sun; Guoxing Ge
Journal:  Aging (Albany NY)       Date:  2021-01-06       Impact factor: 5.682

8.  C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms.

Authors:  Anna Nießen; Simon Schimmack; Marta Sandini; Dominik Fliegner; Ulf Hinz; Magdalena Lewosinska; Thilo Hackert; Markus W Büchler; Oliver Strobel
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

9.  Increased Acid-Producing Diet and Past Smoking Intensity Are Associated with Worse Prognoses Among Breast Cancer Survivors: A Prospective Cohort Study.

Authors:  Tianying Wu; Fang-Chi Hsu; John P Pierce
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.